In addition to the familiar stories of drugs that were developed in one indication and found success in another, such as sildenafil and thalidomide, there are regular reports of such repurposing on a smaller scale. Just last week, new data showed HIV drug Viracept (nelfinavir, Pfizer Inc.) chews up some solid tumors as well. Read More
